Skip to main content
. 2020 Apr 26;21(9):3065. doi: 10.3390/ijms21093065

Figure 2.

Figure 2

Quantitation of purified Bruton’s tyrosine kinase (BTK) concentration by a fluorescence resonance energy transfer (FRET)-based phosphorylation assay, presenting the BTK inhibition activity of the ginsenoside compounds (A). The concentration of Ibrutinib that inhibits 50% of BTK (IC50) was confirmed as 0.63 nM (B).